SCHEMBL5284766

SCHEMBL5284766

N/N=C/Cc1ccncc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LOXL2 Q9Y4K0 2/20 0.46
CYP3A4 P08684 4/20 0.44
ALDH1A1 P00352 4/20 0.44
CYP2D6 P10635 3/20 0.44
CYP1A2 P05177 3/20 0.44
CYP2C9 P11712 2/20 0.44
CYP2C19 P33261 2/20 0.44
HSD17B10 Q99714 1/20 0.44
HRH1 P35367 2/20 0.38
CYP17A1 P05093 1/20 0.36
CYP19A1 P11511 1/20 0.36
CYP11B1 P15538 1/20 0.36
CYP11B2 P19099 1/20 0.36
HRH3 Q9Y5N1 3/20 0.35
TDP1 Q9NUW8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
MEN1 O00255 1/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35
CHRM1 P11229 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10805702 1.00 LOXL2 (0.46) LOXL2CYP3A4ALDH1A1CYP2D6CYP1A2
SCHEMBL4379548 0.77 ALDH1A1 (0.46) LOXL2CYP3A4ALDH1A1CYP2D6CYP1A2
Beta-Phenylethylidene Hydrazine SCHEMBL1051740 0.76 MAOB (0.52) LOXL2ALDH1A1TSHRSMN1; SMN2CA1
Beta-Phenylethylidene Hydrazine SCHEMBL1005101 0.76 MAOB (0.52) LOXL2ALDH1A1TSHRSMN1; SMN2CA1
SCHEMBL6609419 0.75
SCHEMBL15117847 0.73 LOXL2 (0.46) LOXL2ALDH1A1
SCHEMBL28324399 0.72 CYP3A4 (0.40) LOXL2CYP3A4ALDH1A1CYP2D6CYP1A2
SCHEMBL5495225 0.72 CYP3A4 (0.55) LOXL2CYP3A4ALDH1A1CYP2D6CYP1A2
SCHEMBL3408218 0.71 LOXL2 (0.50) LOXL2CYP3A4ALDH1A1CYP2D6CYP1A2
SCHEMBL272745 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007008942-A2 PHENYLAMINO-ACETIC ACID [1-(PYRIDIN-4-YL)-METHYLIDENE]-HYDRAZIDE DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS OF G PROTEIN-COUPLED RECEPTOR KINASES FOR THE TREATMENT OF EYE DISEASES AERIE PHARMACEUTICALS, INC. (US) 2007-01-18 WO disclosed